Re: Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia

被引：0
|
作者：
Atala, Anthony
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 02期
关键词：
D O I：
10.1016/j.juro.2014.11.042
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：731 / 731
页数：1
相关论文
共 50 条
  • [1] Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
    Pupe, Carolina Goncalves
    Do Carmo, Flavia Almada
    De Sousa, Valeria Pereira
    Lopes, Marlene
    Abrahim-Vieira, Barbara
    Ribeiro, Antonio Jose
    Veiga, Francisco
    Rodrigues, Carlos Rangel
    Padula, Cristina
    Santi, Patrizia
    Cabral, Lucio Mendes
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (11) : 4057 - 4064
  • [2] Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (05) : 1209 - 1211
  • [3] The effect of doxazosin, Finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia
    Johnson, Theodore M., II
    Burrows, Pamela K.
    Kusek, John W.
    Nyberg, Leroy M.
    Tenover, J. Lisa
    Lepor, Herbert
    Roehrborn, Claus G.
    JOURNAL OF UROLOGY, 2007, 178 (05): : 2045 - 2050
  • [4] The effect of doxazosin, finasteride, and combination therapy on nocturia in men with benign prostatic hyperplasia
    Johnson, Theodore M., II
    Burrows, Pamela K.
    Kusek, John W.
    Nyberg, Leroy
    Tenover, J. Lisa
    Lepor, Herbert
    Roehrborn, Claus G.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 511 - 511
  • [5] Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia
    Bhardwa, Jeetesh
    Goldstraw, Miles
    Tzortzis, Sevasti
    Kirby, Roger
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1337 - 1344
  • [6] The effect of doxazosin, Finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia - Comment
    Weiss, Jeffrey P.
    JOURNAL OF UROLOGY, 2007, 178 (05): : 2050 - 2051
  • [7] The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
    McConnell, JD
    Roehrborn, CG
    Bautista, OM
    Andriole, GL
    Dixon, CM
    Kusek, JW
    Lepor, H
    McVary, KT
    Nyberg, LM
    Clarke, HS
    Crawford, ED
    Diokno, A
    Foley, JP
    Foster, HE
    Jacobs, SC
    Kaplan, SA
    Kreder, KJ
    Lieber, MM
    Lucia, MS
    Miller, GJ
    Menon, M
    Milam, DF
    Ramsdell, JW
    Schenkman, NS
    Slawin, KM
    Smith, JA
    Kusek, JW
    Nyberg, LM
    Briggs, JP
    McConnell, JD
    Crawford, ED
    Homan, K
    Donohue, R
    Parker, D
    Easterday, K
    Robertson, K
    Kaplan, S
    Wentland, M
    Hardy, L
    Roehrborn, C
    Ahrens, A
    McConnell, J
    Hall, D
    Cutts, D
    Carter, S
    Waldrep, K
    Schenkman, N
    Sanetrik, K
    Sihelnik, S
    Zorn, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25): : 2387 - 2398
  • [8] Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The Prospective European Doxazosin and Combination Therapy (PREDICT) trial
    Kirby, RS
    Roehrborn, C
    Boyle, P
    Bartsch, G
    Jardin, A
    Cary, MM
    Sweeney, M
    Grossman, EB
    UROLOGY, 2003, 61 (01) : 119 - 126
  • [9] Long-Term Effects of Doxazosin, Finasteride and Combination Therapy on Quality of Life in Men with Benign Prostatic Hyperplasia
    Fwu, Chyng-Wen
    Eggers, Paul W.
    Kaplan, Steven A.
    Kirkali, Ziya
    Lee, Jeannette Y.
    Kusek, John W.
    JOURNAL OF UROLOGY, 2013, 190 (01): : 187 - 193
  • [10] Finasteride therapy for benign prostatic hyperplasia
    Helling, Thomas J.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 178 (05) : 596 - 597
12345